【招银国际】Reiterated guidance but we remained cautious.pdf

Prudence guidance with solid fundamentals

1Q in line; 2023 guidance maintained

–2023 guidance cut, expecting recovery in 2024

We expect prudent guidance but decent margins

–Full-year guidance unchanged

Guidance Manual for Independent Evaluation Group Validators

2Q23 was inline and FY23E guidance stayed

Guidance on global monitoring for diabetes prevention and control

China Technology–Global fabless／IDM 2Q23 wrap： expect continued inventory correction for non-AI players; All eyes on NVDA 3Q23E guidance

(Q)SAR Assessment Framework: Guidance for the regulatory assessment of (Quantitative) Structure Activity Relationship models and predictions, Second Edition